Developer docs
API playgroundTry for free, no card

Search company profiles

Miramar Labs

Full company profile

uuid0006lz7

Namestring
Miramar Labs
Legal namestring
miraDry, Inc.
Websiteurl
miradryhcp.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Miramar Labs, Inc. (doing business as miraDry, Inc.) is a privately-held medical device company headquartered in Sunnyvale, California, that developed and commercializes the miraDry system—an FDA 510(k)-cleared device that uses precisely controlled microwave thermal energy to permanently eliminate sweat glands, odor glands, and hair follicles in the underarm. Founded in 2006, the company's core technology delivers non-invasive energy to destroy target glands in a single approximately one-hour procedure, with treated glands not regenerating; published clinical data report 82% sweat reduction at 12 months and 89% of patients no longer bothered by odor at 24 months. The company's intellectual property includes multiple U.S. patents covering its microwave delivery system and registered trademarks (miraDry®, miraDry fresh™).

The company operates a B2B2C business model, selling miraDry capital equipment to licensed healthcare practitioners—including dermatologists, plastic surgeons, and medical aesthetic practices—who in turn administer treatments to patients and set procedure pricing. Revenue mechanics combine hardware sales to providers with downstream procedure fees, supported by a global distributor network spanning more than 50 countries across Asia Pacific, Europe, the Middle East, Africa, and the Americas. Field sales representatives and a provider-locator tool drive patient acquisition.

Historically, the company raised approximately $109.6M in venture funding across multiple rounds (2006-2016) from investors including Aisling Capital, Cross Creek, Domain Associates, Morgenthaler Ventures, Split Rock Partners, and RusnanoMedInvest, and was previously publicly listed (otcqb:MRLB) before delisting. The company continues to operate actively, holds the 2025 Beauty Innovation Award for Body Product of the Year, and maintains a 11-50 employee organization focused on commercial support, marketing, and distributor management.

Short descriptiontext

Miramar Labs (miraDry, Inc.) is a Sunnyvale-based medical device company that develops and sells the FDA-cleared miraDry microwave system to licensed healthcare practitioners worldwide for permanent treatment of underarm sweat, odor, and hair.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSunnyvale, United States
HQ citystring
Sunnyvale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical aesthetic devices, hyperhidrosis treatment, microwave thermal therapy, FDA-cleared dermatology devices, permanent sweat reduction
Industry2 codes
1Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning)
CodeCRABAKAIPrimaryYes
2Microneedling / Collagen Induction Therapy
CodeHSALADAIPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Aesthetic Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1miraDry System Equipment Sales
TypeHardware Sales
Description

Sale of the miraDry system equipment to licensed healthcare providers and medical practices who perform treatments

miradry.com
2Treatment Procedures
TypeProfessional Services
Description

Providers bill patients for treatment procedures. Pricing varies by region and practice.

miradry.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Provider/practice purchase model - pricing not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

miraDry system is sold to healthcare providers. Treatment pricing is set by individual providers and varies by region, practice, and patient needs. Financing options may be available.

miradry.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1miraDry fresh
Description

Brand variant for miraDry fresh product line

miradry.com
Core offering1 text field

Miramar Labs, operating as miraDry, Inc., develops and commercializes the miraDry system, an FDA-cleared medical device that uses precisely controlled microwave thermal energy to permanently eliminate sweat glands, odor glands, and hair follicles in the underarm. The miraDry system hardware is sold to licensed healthcare practitioners (dermatologists, plastic surgeons, and medical aesthetic practices) who administer the approximately one-hour treatment to adult patients with primary axillary hyperhidrosis.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 82% average sweat reduction at 12 months
+1 more record
Product overview1 text field

miraDry, Inc. offers a single unified product—the miraDry system—which is an FDA-cleared medical device treatment for excessive underarm sweat (axillary hyperhidrosis), odor, and unwanted hair. The system uses microwave thermal energy to permanently destroy sweat glands, odor glands, and hair follicles in the underarm. The primary offering is the miraDry treatment system, with a sub-brand variant called miraDry fresh. Treatments are administered by licensed healthcare practitioners and take approximately one hour to complete.

Product and service1 record
1miraDry System
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Venus Concept markets energy-based aesthetic devices (Venus Versa, Venus Legacy, NeoGraft) targeting dermatologists, plastic surgeons, and med-spas. Comparable as a smaller-scale peer in the same energy-based aesthetic device category with a similar razor-blade economics model.

TypeDirect peer
Description

InMode develops RF, laser, and IPL-based aesthetic and wellness platforms for physicians and med-spas. Comparable as a competitor in the energy-based aesthetic device category with similar provider-target GTM and a strong track record of expanding indications.

TypeDirect peer
Description

Cutera manufactures laser and energy-based aesthetic devices (e.g., AviClear, excel V, truSculpt) sold to medical aesthetic practices. Comparable as a peer energy-based aesthetic device company with overlapping provider customers and a recurring consumables model.

TypeEmerging player
Description

Dermadry manufactures consumer and professional iontophoresis devices for the treatment of hyperhidrosis. Comparable as a niche, indication-focused competitor targeting the same hyperhidrosis patient population via a different (non-microwave) modality and direct-to-consumer channel.

TypeEmerging player
Description

BTL Industries produces non-invasive aesthetic and wellness devices (EMSculpt, Emtone, Vanquish) sold to medical aesthetic practices. Comparable as a peer in the energy-based aesthetic device space with overlapping provider customers and expanding indications strategy.

TypeBroad incumbent
Description

Allergan Aesthetics (an AbbVie company) markets Botox — the leading injectable treatment for axillary hyperhidrosis — along with a broader aesthetics portfolio (fillers, body contouring, skincare). Comparable as the dominant incumbent competing with miraDry for hyperhidrosis treatment share and for provider aesthetics wallet.

TypeDirect peer
Description

Cynosure develops energy-based aesthetic medical devices (laser, RF, body contouring) sold to dermatologists and aesthetic practices. Highly comparable to miraDry as a capital-equipment aesthetic medical device company with a similar provider-customer GTM motion.

TypeDirect peer
Description

Alma Lasers (a Sisram Medical company) develops energy-based aesthetic devices (laser, RF, ultrasound) for the global medical aesthetics market. Comparable as a peer in energy-based aesthetic device technology and provider-channel sales.

TypeDirect peer
Description

Solta Medical (a division of Bausch Health) markets energy-based aesthetic systems (Thermage, Fraxel, Clear+Brilliant) to dermatologists and plastic surgeons. Directly comparable in modality, customer base, and capital equipment plus consumable business model.

TypeDirect peer
Description

Sciton manufactures laser and light-based aesthetic and medical platforms (BBL, Halo, Joule) sold to dermatologists and plastic surgeons. Directly comparable as an energy-based aesthetic device company with overlapping clinical indications and provider customer base.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Miramar Labs

Medical Aesthetic Devicesmiradryhcp.com

Miramar Labs (miraDry, Inc.) is a Sunnyvale-based medical device company that develops and sells the FDA-cleared miraDry microwave system to licensed healthcare practitioners worldwide for permanent treatment of underarm sweat, odor, and hair.

What Miramar Labs does

Miramar Labs, Inc. (doing business as miraDry, Inc.) is a privately-held medical device company headquartered in Sunnyvale, California, that developed and commercializes the miraDry system—an FDA 510(k)-cleared device that uses precisely controlled microwave thermal energy to permanently eliminate sweat glands, odor glands, and hair follicles in the underarm. Founded in 2006, the company's core technology delivers non-invasive energy to destroy target glands in a single approximately one-hour procedure, with treated glands not regenerating; published clinical data report 82% sweat reduction at 12 months and 89% of patients no longer bothered by odor at 24 months. The company's intellectual property includes multiple U.S. patents covering its microwave delivery system and registered trademarks (miraDry®, miraDry fresh™).

The company operates a B2B2C business model, selling miraDry capital equipment to licensed healthcare practitioners—including dermatologists, plastic surgeons, and medical aesthetic practices—who in turn administer treatments to patients and set procedure pricing. Revenue mechanics combine hardware sales to providers with downstream procedure fees, supported by a global distributor network spanning more than 50 countries across Asia Pacific, Europe, the Middle East, Africa, and the Americas. Field sales representatives and a provider-locator tool drive patient acquisition.

Historically, the company raised approximately $109.6M in venture funding across multiple rounds (2006-2016) from investors including Aisling Capital, Cross Creek, Domain Associates, Morgenthaler Ventures, Split Rock Partners, and RusnanoMedInvest, and was previously publicly listed (otcqb:MRLB) before delisting. The company continues to operate actively, holds the 2025 Beauty Innovation Award for Body Product of the Year, and maintains a 11-50 employee organization focused on commercial support, marketing, and distributor management.

Miramar Labs firmographics

Firmographics
Name
Miramar Labs
Legal name
miraDry, Inc.
Website
https://miradryhcp.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Miramar Labs (miraDry, Inc.) is a Sunnyvale-based medical device company that develops and sells the FDA-cleared miraDry microwave system to licensed healthcare practitioners worldwide for permanent treatment of underarm sweat, odor, and hair.
Ownership category
akta.pro rank

Miramar Labs industry classification

Industry
Product category
Medical Aesthetic Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI)
akta.pro secondary industry
Microneedling / Collagen Induction Therapy (HSALADAI)

Keywords

  • Medical aesthetic devices
  • Hyperhidrosis treatment
  • Microwave thermal therapy
  • FDA-cleared dermatology devices
  • Permanent sweat reduction

Where Miramar Labs is headquartered

Location

Headquarters

HQ city
Sunnyvale
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Miramar Labs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. miraDry System Equipment Sales: Sale of the miraDry system equipment to licensed healthcare providers and medical practices who perform treatments
  2. Treatment Procedures: Providers bill patients for treatment procedures. Pricing varies by region and practice.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProvider/practice purchase model - pricing not publicly disclosed

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Miramar Labs product offering

Product offering

Core offering

Miramar Labs, operating as miraDry, Inc., develops and commercializes the miraDry system, an FDA-cleared medical device that uses precisely controlled microwave thermal energy to permanently eliminate sweat glands, odor glands, and hair follicles in the underarm. The miraDry system hardware is sold to licensed healthcare practitioners (dermatologists, plastic surgeons, and medical aesthetic practices) who administer the approximately one-hour treatment to adult patients with primary axillary hyperhidrosis.

Product overview

miraDry, Inc. offers a single unified product—the miraDry system—which is an FDA-cleared medical device treatment for excessive underarm sweat (axillary hyperhidrosis), odor, and unwanted hair. The system uses microwave thermal energy to permanently destroy sweat glands, odor glands, and hair follicles in the underarm. The primary offering is the miraDry treatment system, with a sub-brand variant called miraDry fresh. Treatments are administered by licensed healthcare practitioners and take approximately one hour to complete.

Differentiator

Problem solved

Functional benefit

Brands

  • miraDry fresh: Brand variant for miraDry fresh product line

Products and services

  • miraDry System

Quantifiable outcome

  • 82% average sweat reduction at 12 months
  • +1 more outcomes

Companies that use Miramar Labs

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Miramar Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Miramar Labs partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Miramar Labs competitors and assessment

Company assessment

Direct peers

  • Venus Concept: Venus Concept markets energy-based aesthetic devices (Venus Versa, Venus Legacy, NeoGraft) targeting dermatologists, plastic surgeons, and med-spas. Comparable as a smaller-scale peer in the same energy-based aesthetic device category with a similar razor-blade economics model.
  • InMode: InMode develops RF, laser, and IPL-based aesthetic and wellness platforms for physicians and med-spas. Comparable as a competitor in the energy-based aesthetic device category with similar provider-target GTM and a strong track record of expanding indications.
  • Cutera: Cutera manufactures laser and energy-based aesthetic devices (e.g., AviClear, excel V, truSculpt) sold to medical aesthetic practices. Comparable as a peer energy-based aesthetic device company with overlapping provider customers and a recurring consumables model.
  • Cynosure: Cynosure develops energy-based aesthetic medical devices (laser, RF, body contouring) sold to dermatologists and aesthetic practices. Highly comparable to miraDry as a capital-equipment aesthetic medical device company with a similar provider-customer GTM motion.
  • Alma Lasers: Alma Lasers (a Sisram Medical company) develops energy-based aesthetic devices (laser, RF, ultrasound) for the global medical aesthetics market. Comparable as a peer in energy-based aesthetic device technology and provider-channel sales.
  • Solta Medical: Solta Medical (a division of Bausch Health) markets energy-based aesthetic systems (Thermage, Fraxel, Clear+Brilliant) to dermatologists and plastic surgeons. Directly comparable in modality, customer base, and capital equipment plus consumable business model.
  • Sciton: Sciton manufactures laser and light-based aesthetic and medical platforms (BBL, Halo, Joule) sold to dermatologists and plastic surgeons. Directly comparable as an energy-based aesthetic device company with overlapping clinical indications and provider customer base.

Emerging players

  • Dermadry: Dermadry manufactures consumer and professional iontophoresis devices for the treatment of hyperhidrosis. Comparable as a niche, indication-focused competitor targeting the same hyperhidrosis patient population via a different (non-microwave) modality and direct-to-consumer channel.
  • BTL Industries: BTL Industries produces non-invasive aesthetic and wellness devices (EMSculpt, Emtone, Vanquish) sold to medical aesthetic practices. Comparable as a peer in the energy-based aesthetic device space with overlapping provider customers and expanding indications strategy.

Broad incumbents

  • Allergan Aesthetics (AbbVie): Allergan Aesthetics (an AbbVie company) markets Botox — the leading injectable treatment for axillary hyperhidrosis — along with a broader aesthetics portfolio (fillers, body contouring, skincare). Comparable as the dominant incumbent competing with miraDry for hyperhidrosis treatment share and for provider aesthetics wallet.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

Miramar Labs social profiles

Digital presence

Miramar Labs compliance and trust

Trust signal

Compliance1 record

Miramar Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Miramar Labs leadership team

Management profile

Number of profiles

Miramar Labs funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Miramar Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Miramar Labs

What does Miramar Labs do?

Miramar Labs, operating as miraDry, Inc., develops and commercializes the miraDry system, an FDA-cleared medical device that uses precisely controlled microwave thermal energy to permanently eliminate sweat glands, odor glands, and hair follicles in the underarm. The miraDry system hardware is sold to licensed healthcare practitioners (dermatologists, plastic surgeons, and medical aesthetic practices) who administer the approximately one-hour treatment to adult patients with primary axillary hyperhidrosis.

Is Miramar Labs a public or private company?

Miramar Labs is a private company. It is classified as venture growth investor backed and is currently operating.

When was Miramar Labs founded?

Miramar Labs was founded in 2006. It employs 11 to 50 people.

Where is Miramar Labs based?

Miramar Labs is headquartered in Sunnyvale, United States, in the North America region.

How does Miramar Labs make money?

Two revenue lines are on record. miraDry System Equipment Sales are the primary driver. The others are treatment Procedures.

Who are Miramar Labs's main competitors?

Direct peers on record are Venus Concept, InMode, Cutera, Cynosure, Alma Lasers, Solta Medical and Sciton. Emerging players are Dermadry and BTL Industries. Allergan Aesthetics (AbbVie) is listed as a broad incumbent.

Does Miramar Labs have an API?

No public API is recorded for Miramar Labs.

What industry is Miramar Labs in?

Miramar Labs's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is CRABAKAI, Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning), with a secondary code of HSALADAI, Microneedling / Collagen Induction Therapy. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Miramar Labs, Inc. - MRLBLaw firm Monteverde & Associates PC announced an investigation into Miramar Labs, Inc. regarding its sale to affiliates of Sientra, Inc., where shareholders are set to receive only $0.3149 per share in cash. The investigation will examine whether Miramar Labs and its Board of Directors violated securities laws or breached fiduciary duties by failing to conduct a fair process and potentially undervaluing the company. Shareholders who wish to obtain additional information or protect their investments are directed to contact the firm.GlobeNewswireMiramar Labs, Inc.® Reports Q1 2017 Financial ResultsMiramar Labs reported Q1 2017 revenue of $3.8 million, down 11% year-over-year, with gross margin expanding to 56%. The company posted a net loss of $7.3 million, and cash and cash equivalents stood at $1.1 million as of March 31, 2017.GlobeNewswireMiramar Labs, Inc.® Reports Fourth Quarter and FullMiramar Labs reported Q4 2016 revenue of $4.4 million, down 18% year-over-year, and full-year revenue of $20.4 million, up 19%. Gross margin expanded to 55% in 2016, and the company recorded a net loss of $20.4 million for the year.GlobeNewswireMiramar Labs, Inc. to Present at Ladenburg Thalmann 2nd Annual Healthcare ConferenceMiramar Labs will present at the Ladenburg Thalmann Healthcare Conference in New York on September 27, 2016, at 1:00 p.m. ET. An audio webcast will be available online, with a replay for 90 days. The company's miraDry procedure has treated over 70,000 patients worldwide.GlobeNewswireMiramar Labs, Inc.® to Present at Wedbush PacGrow Healthcare ConferenceMiramar Labs, a global aesthetic medical device company, will present at the Wedbush PacGrow Healthcare Conference in New York on August 16, 2016. The presentation will be available as an audio webcast online, with a replay for 90 days. The company's miraDry procedure has treated over 70,000 patients worldwide.GlobeNewswireMiramar Labs, Inc. ® Reports Record Second Quarter 2016 Financial ResultsMiramar Labs reported Q2 2016 revenue of $7.4 million, up 47% year-over-year, and completed an Alternative Public Offering. The company shipped a record number of miraDry systems and consumables, with a global installed base of about 800 systems. It also entered a distribution agreement with MEHECO for China.GlobeNewswireMiramar Labs, Inc. Completes Alternative Public Offering, Raises $9.0 MillionMiramar Labs completed a reverse merger with Miramar Technologies and raised approximately $9.0 million from a private placement of 1.8 million shares. The funds will support commercialization of the miraDry system, development of new products, and general corporate purposes. The company plans to file a registration statement for resale of the shares within 90 days.VC News DailyMiramar Labs Secures $10M in Series DMiramar Labs announced it has raised $10 million in Series D funding to expand its commercialization and global sales efforts for the miraDry System, a non-invasive treatment for underarm sweat. This funding will also support the development of new technology platforms following their recent CE Mark approval in Europe. The company reported significant growth in 2013, with increased awareness of their product both in the U.S. and internationally.FinSMEsMiramar Labs Raises $10M in Series D FundingMiramar Labs, a Sunnyvale-based medical device maker, raised $10M in Series D funding from Aisling Capital, Cross Creek Capital, Domain Associates, Morgenthaler Ventures, and RusnanoMedInvest. The company will use the capital to expand global sales, support commercialization in Europe after CE Mark approval, and fund R&D for new indications.